Project Grant R21AR084283

Award Date 6/1/24
Completion Date 5/31/26
Dollars Obligated $213K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $618,629 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to The Regents of the University of Colorado to establish a new "microphysiological joint-on-chip" system. The objective is to create a realistic human joint model that can support mechanistic study of arthritic diseases and rapid testing of candidate treatments. The researchers plan to develop...
This Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop computational tools to accurately predict and interpret different patterns of knee pain in patients with osteoarthritis. The $348,680 award, with a period of performance from Sep 26, 2024 to Aug 31, 2026, will enable researchers at the University of Arizona to: 1) Adapt a...
This $468,769 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research supports preclinical research to identify effective physical therapy and biological intervention strategies to reduce post-traumatic joint contracture (PTJC) following joint injury, particularly in the elbow. The key objectives are to: 1) Determine the optimal parameters of active...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $783,176 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to Mayo Clinic to develop and validate a quantitative spine imaging methodology using photon-counting detector computed tomography (PCD-CT) for comprehensive assessment of bone quality. This 2-year project aims to enable accurate characterization of cortical and trabecular bone microstructure in osteoporotic...
This $1,024,510 National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases project grant funds research at the University of California, San Francisco into simultaneous imaging of tissue biochemistry and metabolism associated with biomechanics in patellofemoral joint osteoarthritis. The research will conduct a longitudinal cohort study of 100 individuals with isolated patellofemoral joint osteoarthritis followed over two time points. Simultaneous positron...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop optical redox imaging (ORI) as a diagnostic and evaluative tool for osteoarthritis (OA) and other cartilage diseases. The $359,207 award, valid from September 1, 2024 to August 31, 2028, will be used to: 1) develop a stress test to diagnose cartilage disease based on changes in ORI...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is intended to support the development of pre-operative planning software for the surgical treatment of patellar instability. The $292,954 award to Ortho Haus, LLC will fund work to generate data, validate computational models, and demonstrate proof-of-concept for a software platform that...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,816,884 Project Grant (R01EB035559) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) to the Children's Research Institute to develop an image-guided robotic assistance system to improve the precision and reduce X-ray dose in orthopedic surgery for pediatric slipped capital femoral epiphysis (SCFE). The key objectives are to: 1)...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to evaluate the use of digital tomosynthesis of the wrist (DWT) to monitor bone quality changes in breast cancer patients receiving aromatase inhibitor therapy. The $651,514 award, with a period of performance from June 2025 to May 2030, will support a longitudinal and cross-sectional...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is developing the X-Visual, a sensor to track fracture healing in cannulated screws used for hip fracture fixation. The $299,999 award to Aravis Biotech LLC will cover the design, computational modeling, and initial testing of this innovative device that can non-invasively measure screw bending...

ONE-STOP-SHOP EARLY DIAGNOSIS OF JOINT INSTABILITY USING AI-ASSISTED 6D COMPUTED TOMOGRAPHY - PROJECT SUMMARY/ABSTRACT AROUND 80 MILLION US ADULTS WILL HAVE ARTHRITIS BY 2040, WHICH CAUSES A SIGNIFICANT SOCIETAL PROBLEM RESULTING IN AN ANNUAL HEALTHCARE COST OF > $136.8 BILLION. THESE PROGRESSIVE DEGENERATIVE DISEASES RESULT IN LONG-TERM FUNCTIONAL DISABILITIES AND MORBIDITIES LEADING TO ACTIVITY LIMITATIONS AND PRODUCTIVITY LOSS. JOINT INSTABILITY TYPICALLY PRECEDES BEFORE THE SYMPTOM ONSET, BUT IT IS TYPICALLY NOT DETECTABLE IN STANDARD IMAGING EXAMS. PATIENTS CAN THEREFORE SUFFER FOR YEARS, AS SYMPTOMS WORSEN BEFORE AN ACCURATE DIAGNOSIS IS MADE. THERE IS A CRITICAL NEED FOR AN ACCURATE IMAGING TECHNIQUE FOR EARLY DIAGNOSIS, WHICH IS CRUCIAL TO PROVIDING THE MOST EFFECTIVE MEDICATIONS, THERAPIES, AND SURGICAL INTERVENTIONS AND RESTORING JOINT FUNCTION BEFORE THE ONSET OF DISABLING SYMPTOMS. VARIOUS LIMITATIONS HAVE HINDERED THE ACCURATE DETECTION OF JOINT INSTABILITY IN STANDARD IMAGING EXAMS: RADIOGRAPHY AND FLUOROSCOPY CANNOT VISUALIZE 3-DIMENSIONAL (3D) JOINT ANATOMY; ULTRASOUND LACKS VISUALIZATION OF BONE STRUCTURE; STATIC MRI/CT CANNOT ASSESS THE EFFECT OF DYNAMIC STRUCTURAL AND BIOMECHANICAL PATHOLOGIES. ACCURATE DIAGNOSIS IS THEREFORE OFTENTIMES ACQUIRED USING INVASIVE ARTHROSCOPY, WHICH EXPOSES PATIENTS TO RISKS OF THE ASSOCIATED COMPLICATIONS. ALTHOUGH THERE HAVE BEEN SOME RECENT ADVANCEMENTS IN 4D (3D + TIME) CT TO PROVIDE DYNAMIC IMAGING CAPABILITY, ITS CLINICAL USE IS LIMITED DUE TO (1) JOINT MOTION ARTIFACTS THAT AFFECT ACCURATE ANATOMICAL AND FUNCTIONAL ANALYSES, AND (2) POOR SOFT-TISSUE VISUALIZATION THAT PROHIBITS ROBUST ASSESSMENT OF CONNECTIVE TISSUE INVOLVEMENT. THE SPECIFIC GOAL OF THIS APPLICATION IS TO DEVELOP AND VALIDATE A NEW DIAGNOSTIC IMAGING TECHNIQUE - 6DCT (3D + TIME + SPECTRAL INFORMATION + KINEMATICS) IN COMBINATION WITH CUSTOM DEEP-LEARNING METHODS. THE 6DCT WILL PROVIDE AN ACCURATE, INFORMATIVE, ONE-STOP-SHOP DIAGNOSTIC TOOL TO ASSESS EARLY DYNAMIC JOINT PATHOLOGIES BEFORE THE ONSET OF ARTHRITIS, WHICH WILL OBVIATE THE NEED FOR INVASIVE TESTS AND PROCEDURES, WITH IMPROVED PATIENT CARE AND ASSOCIATED COST SAVINGS. WE WILL ACCOMPLISH THIS GOAL THROUGH THREE SPECIFIC AIMS: 1. DEVELOP A ROBUST MOTION CORRECTION TECHNIQUE FOR DYNAMIC JOINT IMAGING. 2. DEVELOP A SPECTRAL POST-PROCESSING TECHNIQUE FOR CHARACTERIZING CONNECTIVE TISSUE INVOLVEMENT. 3. DEMONSTRATE THE FEASIBILITY OF 6DCT IN IMAGING DYNAMIC JOINT PATHOLOGY. THIS WORK IS THE FIRST TO DEVELOP INNOVATIVE 6DCT AS A ROBUST DYNAMIC IMAGING TOOL FOR BOTH BONE AND CONNECTIVE TISSUES, AND TO PROVIDE NEW ANATOMICAL AND FUNCTIONAL INFORMATION TO FACILITATE ASSESSING DYNAMIC JOINT PATHOLOGIES. THESE CAPABILITIES HAVE CLINICAL SIGNIFICANCE AS THEY WILL ENABLE EARLY DIAGNOSIS OF JOINT INSTABILITY, WHICH WILL SUBSEQUENTLY ENABLE EARLY INTERVENTIONS THAT WILL IMPROVE PATIENT HEALTH. THIS PROPOSAL WILL DEVELOP THE ESSENTIAL TECHNIQUES AND PRELIMINARY DATA FOR FUTURE LARGE COHORT PROSPECTIVE PATIENT STUDIES.

Posted 6/1/24, 12:00 AM